Consensus Guidelines for the Design and In Vitro Preclinical Efficacy Testing N-of-1 Exon Skipping Antisense Oligonucleotides

Antisense oligonucleotides (ASOs) can modulate pre-mRNA splicing. This offers therapeutic opportunities for numerous genetic diseases, often in a mutation-specific and sometimes even individual-specific manner. Developing therapeutic ASOs for as few as even a single patient has been shown feasible w...

Descripción completa

Detalles Bibliográficos
Autores principales: Aartsma-Rus, Annemieke, Garanto, Alejandro, van Roon-Mom, Willeke, McConnell, Erin M., Suslovitch, Victoria, Yan, Winston X., Watts, Jonathan K., Yu, Timothy W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2023
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940807/
https://www.ncbi.nlm.nih.gov/pubmed/36516128
http://dx.doi.org/10.1089/nat.2022.0060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940807/
https://www.ncbi.nlm.nih.gov/pubmed/36516128
http://dx.doi.org/10.1089/nat.2022.0060

Ejemplares similares